Ventricular TLR4 Levels Abrogate TLR2-Mediated Adverse Cardiac Remodeling upon Pressure Overload in Mice

Involvement of the Toll-like receptor 4 (TLR4) in maladaptive cardiac remodeling and heart failure (HF) upon pressure overload has been studied extensively, but less is known about the role of TLR2. Interplay and redundancy of TLR4 with TLR2 have been reported in other organs but were not investigated during cardiac dysfunction. We explored whether TLR2 deficiency leads to less adverse cardiac remodeling upon chronic pressure overload and whether TLR2 and TLR4 additively contribute to this. We subjected 35 male C57BL/6J mice (wildtype (WT) or TLR2 knockout (KO)) to sham or transverse aortic constriction (TAC) surgery. After 12 weeks, echocardiography and electrocardiography were performed, and hearts were extracted for molecular and histological analysis. TLR2 deficiency (n = 14) was confirmed in all KO mice by PCR and resulted in less hypertrophy (heart weight to tibia length ratio (HW/TL), smaller cross-sectional cardiomyocyte area and decreased brain natriuretic peptide (BNP) mRNA expression, p < 0.05), increased contractility (QRS and QTc, p < 0.05), and less inflammation (e.g., interleukins 6 and 1β, p < 0.05) after TAC compared to WT animals (n = 11). Even though TLR2 KO TAC animals presented with lower levels of ventricular TLR4 mRNA than WT TAC animals (13.2 ± 0.8 vs. 16.6 ± 0.7 mg/mm, p < 0.01), TLR4 mRNA expression was increased in animals with the largest ventricular mass, highest hypertrophy, and lowest ejection fraction, leading to two distinct groups of TLR2 KO TAC animals with variations in cardiac remodeling. This variation, however, was not seen in WT TAC animals even though heart weight/tibia length correlated with expression of TLR4 in these animals (r = 0.078, p = 0.005). Our data suggest that TLR2 deficiency ameliorates adverse cardiac remodeling and that ventricular TLR2 and TLR4 additively contribute to adverse cardiac remodeling during chronic pressure overload. Therefore, both TLRs may be therapeutic targets to prevent or interfere in the underlying molecular processes.

[1]  Aditi Jain,et al.  Toll-like receptor 2 deficiency hyperactivates the FoxO1 transcription factor and induces aging-associated cardiac dysfunction in mice , 2018, The Journal of Biological Chemistry.

[2]  Lili Yu,et al.  The Role of Toll-Like Receptor Signaling in the Progression of Heart Failure , 2018, Mediators of inflammation.

[3]  T. V. van Veen,et al.  Leukocytic Toll-Like Receptor 2 Deficiency Preserves Cardiac Function And Reduces Fibrosis In Sustained Pressure Overload , 2017, Scientific Reports.

[4]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[5]  S. Epelman,et al.  Chronic Heart Failure and Inflammation: What Do We Really Know? , 2016, Circulation research.

[6]  P. Knuefermann,et al.  Tlr2 deficiency does not limit the development of left ventricular hypertrophy in a model of transverse aortic constriction induced pressure overload , 2016, Journal of Negative Results in BioMedicine.

[7]  G. Baumgarten,et al.  Tlr4 Deficiency Protects against Cardiac Pressure Overload Induced Hyperinflammation , 2015, PloS one.

[8]  Yin Wang,et al.  Up‐regulated TLR4 in cardiomyocytes exacerbates heart failure after long‐term myocardial infarction , 2015, Journal of cellular and molecular medicine.

[9]  Rachel S. Levy-Drummer,et al.  TLR4 Expression Is Associated with Left Ventricular Dysfunction in Patients Undergoing Coronary Artery Bypass Surgery , 2015, PloS one.

[10]  Yongquan Wu,et al.  Toll-Like Receptor 4 Knockout Protects Against Isoproterenol-Induced Cardiac Fibrosis , 2015, Journal of cardiovascular pharmacology and therapeutics.

[11]  Yongquan Wu,et al.  GW25-e1129 Toll-like Receptor 4 Knockout Protects Against Isoproterenol-induced Cardiac Fibrosis: The Role of Autophagy , 2014 .

[12]  Taro Kawai,et al.  Toll-Like Receptor Signaling Pathways , 2014, Front. Immunol..

[13]  Yu Zhou,et al.  Toll‐like receptor 2/4 heterodimer mediates inflammatory injury in intracerebral hemorrhage , 2014, Annals of neurology.

[14]  Hui-Hua Li,et al.  Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation. , 2014, Cardiovascular research.

[15]  M. Vos,et al.  Changes in Cx43 and NaV1.5 Expression Precede the Occurrence of Substantial Fibrosis in Calcineurin-Induced Murine Cardiac Hypertrophy , 2014, PloS one.

[16]  Joel Stein,et al.  Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[17]  Ruhang Tang,et al.  Cardiomyocyte-specific p65 NF-κB deletion protects the injured heart by preservation of calcium handling. , 2013, American journal of physiology. Heart and circulatory physiology.

[18]  M. Lindsey,et al.  Correction: Toll-Like Receptor (TLR) 2 and TLR4 Differentially Regulate Doxorubicin Induced Cardiomyopathy in Mice , 2012, PLoS ONE.

[19]  M. Lindsey,et al.  Toll-Like Receptor (TLR) 2 and TLR4 Differentially Regulate Doxorubicin Induced Cardiomyopathy in Mice , 2012, PloS one.

[20]  D. Good,et al.  Toll-like Receptor 2 Is Required for LPS-induced Toll-like Receptor 4 Signaling and Inhibition of Ion Transport in Renal Thick Ascending Limb* , 2012, The Journal of Biological Chemistry.

[21]  P. Knuefermann,et al.  The toll‐like receptor 4‐antagonist eritoran reduces murine cardiac hypertrophy , 2011, European journal of heart failure.

[22]  D. Mann The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. , 2011, Circulation research.

[23]  D. Davies,et al.  The structural biology of Toll-like receptors. , 2011, Structure.

[24]  C. Glass,et al.  FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages , 2010, The EMBO journal.

[25]  A. Bartke,et al.  Smaller cardiac cell size and reduced extra-cellular collagen might be beneficial for hearts of Ames dwarf mice , 2010, International journal of biological sciences.

[26]  M. Vos,et al.  Heterogeneous Connexin43 distribution in heart failure is associated with dispersed conduction and enhanced susceptibility to ventricular arrhythmias , 2010, European journal of heart failure.

[27]  P. Doevendans,et al.  Myocardial Ischemia / Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti – Toll-Like Receptor-2 Antibody , 2009 .

[28]  S. Akira,et al.  ROLE OF TOLL-LIKE RECEPTORS 2 AND 4, AND THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS IN HIGH-MOBILITY GROUP BOX 1-INDUCED INFLAMMATION IN VIVO , 2009, Shock.

[29]  C. Schneider,et al.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.

[30]  M. Goumans,et al.  Toll-Like Receptor 4 Mediates Maladaptive Left Ventricular Remodeling and Impairs Cardiac Function After Myocardial Infarction , 2008, Circulation research.

[31]  R. Tapping,et al.  Microbial Products Stimulate Human Toll-like Receptor 2 Expression through Histone Modification Surrounding a Proximal NF-κB-binding Site* , 2007, Journal of Biological Chemistry.

[32]  S. Gerondakis,et al.  The FASEB Journal • FJ Express Full-Length Article Absence of NF-�B subunit p50 improves heart failure after myocardial infarction , 2022 .

[33]  H. Methe,et al.  Expansion of Circulating Toll-Like Receptor 4–Positive Monocytes in Patients With Acute Coronary Syndrome , 2005, Circulation.

[34]  A. Khaghani,et al.  Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[35]  Osamu Takeuchi,et al.  Toll-Like Receptor-2 Modulates Ventricular Remodeling After Myocardial Infarction , 2002, Circulation.

[36]  B. Zwilling,et al.  NFκB and Sp1 Elements Are Necessary for Maximal Transcription of Toll-like Receptor 2 Induced by Mycobacterium avium1 , 2001, The Journal of Immunology.

[37]  A. Medvedev,et al.  Bacterial Lipopolysaccharide and IFN-γ Induce Toll-Like Receptor 2 and Toll-Like Receptor 4 Expression in Human Endothelial Cells: Role of NF-κB Activation1 , 2001, The Journal of Immunology.

[38]  Jun Ma,et al.  Toll-Like Receptors 2 and 4 Predict New-Onset Atrial Fibrillation in Acute Myocardial Infarction Patients. , 2018, International heart journal.

[39]  Jan J Piek,et al.  Arteriogenesis requires toll-like receptor 2 and 4 expression in bone-marrow derived cells. , 2011, Journal of molecular and cellular cardiology.

[40]  B. Swynghedauw,et al.  Molecular mechanisms of myocardial remodeling. , 1999, Physiological reviews.